rs587783114
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BA1BS2_Supporting
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ala486_Lys487del variant in CDKL5 is 0.03% in Latino/Admixed American sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Ala486_Lys487del variant is observed in 1 unaffected individual (RettBASE, PMID 22867051) (BS2_supporting). In summary, the p.Ala486_Lys487del variant in CDKL5 is classified as benign based on the ACMG/AMP criteria applied (BA1, BS2_supporting). LINK:https://erepo.genome.network/evrepo/ui/classification/CA199357/MONDO:0100039/016
Frequency
Consequence
ENST00000623535.2 inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.1455_1460del | p.Ala486_Lys487del | inframe_deletion | 12/18 | ENST00000623535.2 | NP_001310218.1 | |
CDKL5 | NM_001037343.2 | c.1455_1460del | p.Ala486_Lys487del | inframe_deletion | 13/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.1455_1460del | p.Ala486_Lys487del | inframe_deletion | 12/21 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.1455_1460del | p.Ala486_Lys487del | inframe_deletion | 12/18 | 1 | NM_001323289.2 | ENSP00000485244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000270 AC: 3AN: 111061Hom.: 0 Cov.: 22 AF XY: 0.0000601 AC XY: 2AN XY: 33303
GnomAD3 exomes AF: 0.0000660 AC: 12AN: 181925Hom.: 0 AF XY: 0.0000600 AC XY: 4AN XY: 66647
GnomAD4 exome AF: 0.0000985 AC: 108AN: 1096500Hom.: 0 AF XY: 0.000113 AC XY: 41AN XY: 362182
GnomAD4 genome AF: 0.0000270 AC: 3AN: 111061Hom.: 0 Cov.: 22 AF XY: 0.0000601 AC XY: 2AN XY: 33303
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2016 | The c.1455_1460delGGCCAA variant in the CDKL5 gene has been previously identified in a female patient with developmental delay, absent speech, seizures, and difficulty walking; however, it was classified by the authors as a variant of unknown significance because it was inherited from her unaffected mother and both the patient and her mother had normal X-inactivation studies (Maortua et al., 2012). The variant results in an in-frame deletion of two amino acids. Therefore, based on the currently available information, it is unclear whether c.1455_1460delGGCCAA is a pathogenic variant or a rare benign variant. - |
not specified Benign:1
Likely benign, no assertion criteria provided | curation | RettBASE | May 09, 2014 | Found in unaffected female - |
CDKL5 disorder Benign:1
Benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Feb 18, 2022 | The allele frequency of the p.Ala486_Lys487del variant in CDKL5 is 0.03% in Latino/Admixed American sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Ala486_Lys487del variant is observed in 1 unaffected individual (RettBASE, PMID 22867051) (BS2_supporting). In summary, the p.Ala486_Lys487del variant in CDKL5 is classified as benign based on the ACMG/AMP criteria applied (BA1, BS2_supporting). - |
CDKL5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at